IPCALAB.NS Cash Flow
Ipca Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹805.81 Cr. | ₹944.65 Cr. | ₹1,321.32 Cr. | ₹1,141.97 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-725.00 Cr. | ₹-1,291.79 Cr. | ₹-869.50 Cr. | ₹-246.77 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹507.24 Cr. | ₹-552.55 Cr. | ₹-282.98 Cr. | ₹-753.53 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹588.05 Cr. | ₹-899.69 Cr. | ₹168.84 Cr. | ₹141.67 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹990.93 Cr. | ₹1,655.48 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from IPCALAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).